Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
PET-scan toont effect van bevacizumab bij kinderen met diffuus intrinsiek ponsglioom
mei 2017 | Neuro-oncologie